Kota Takahashi

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
Kota Takahashi
Publication record
275 papers · 5,041 citations · H-index 37

PAPERS

Long-term CMV monitoring and chronic rejection in renal transplant recipients
202311 citationsauthor #6
Acquisition of Antibody Against Cytomegalovirus After Kidney Transplantation in Seronegative Recipients.
20232 citationsauthor #6
Hyporesponsiveness against donor’s ABO antigens of renal grafts after ABO-incompatible kidney transplantation
20221 citationsauthor #10
MP36-05 A NOVEL METHOD OF CD31 COMBINED ABO CARBOHYDRATE ANTIGEN MICROARRAY PREDICTS ACUTE ANTIBODY MEDIATED REJECTION IN ABO-INCOMPATIBLE KIDNEY TRANSPLANTATION
20220 citationsauthor #12
A Novel Method of CD31-Combined ABO Carbohydrate Antigen Microarray Predicts Acute Antibody-Mediated Rejection in ABO-Incompatible Kidney Transplantation
20226 citationsauthor #16
Efficacy and safety of colorectal endoscopic submucosal dissection in patients with sarcopenia
20204 citationsauthor #4
[PLASMA RENIN ACTIVITY AND ALDOSTERONE IN RENAL TRANSPLANT PATIENTS].
20201 citationsauthor #5
[RESULTS OF TONSILLECTOMY AND STEROID PULSE THERAPY IN 20 CASES OF RECURRENT IgA NEPHROPATHY AFTER KIDNEY TRANSPLANTATION].
20190 citationsauthor #13
Analysis of the prevalence of systemic de novo thrombotic microangiopathy after ABO‐incompatible kidney transplantation and the associated risk factors
201921 citationsauthor #10
Abstract 1535: CBA-1205, a novel glycoengineered humanized antibody targeting DLK-1 exhibits potent anti-tumor activity in DLK-1 expressing tumor xenograft models
20191 citationsauthor #2
Bortezomib Eliminates Plasma Cells From a Renal Graft in Plasma Cell-Rich Acute Rejection.
201911 citationsauthor #14
Bortezomib Eliminates Plasma Cells from the Renal Graft in Plasma Cell-Rich Acute Rejection
20183 citationsauthor #9
Management of Juvenile Idiopathic Arthritis in ABO-incompatible Kidney Transplantation: A Case Report.
20182 citationsauthor #8
Is it Really Necessary to Remove anti-A/B Antibodies in ABO-Incompatible Kidney Transplantation?
20181 citationsauthor #4
Outcomes of Pediatric ABO-incompatible Living Kidney Transplantations From 2002 to 2015: An Analysis of the Japanese Kidney Transplant Registry
201820 citationsauthor #7
[LONG-TERM OUTCOME OF PEDIATRIC KIDNEY TRANSPLANTATION: A SINGLE-CENTER EXPERIENCES].
20181 citationsauthor #11
The Examination of Hepatitis E after Renal Transplantation
20180 citationsauthor #4
Long-Term Outcome of Kidney Transplantation for IgA Nephropathy: A Single-Center Experiences
20180 citationsauthor #8
SP774OUTCOME OF PEDIATRIC ABO-INCOMPATIBLE LIVING KIDNEY TRANSPLANTATION BETWEEN 2002 AND 2014: AN ANALYSIS OF THE JAPANESE KIDNEY TRANSPLANT REGISTRY
20172 citationsauthor #6
Results of a multicenter prospective clinical study in Japan for evaluating efficacy and safety of desensitization protocol based on rituximab in ABO-incompatible kidney transplantation
201720 citationsauthor #1
ARTERIOLAR HYALINIZATION PREDICTS CLINICAL OUTCOME IN RENAL TRANSPLANTATION FROM DONORS AFTER CARDIAC DEATH.: MP74‐01
20170 citationsauthor #7
PRE‐TRANSPLANT ANTIBODY REMOVAL CAN BE AVOIDED IN ABO INCOMPATIBLE KIDNEY TRANSPLANTATION.: MP06‐06
20170 citationsauthor #7
A Prospective Randomized, Comparative Trial of High-Dose Mizoribine Versus Mycophenolate Mofetil in Combination With Tacrolimus and Basiliximab for Living Donor Renal Transplant: A Multicenter Trial.
20169 citationsauthor #6
[ABO-incompatible kidney transplantation].
2016101 citationsauthor #3
FP857DESENSITIZATION WITH RITUXIMAB IN ABO INCOMPATIBLE KIDNEY TRANSPLANTATION IN JAPAN
20150 citationsauthor #2
Trends in ABO-incompatible kidney transplantation.
201521 citationsauthor #3
Immune monitoring with a lymphocyte adenosine triphosphate assay in kidney transplant recipients treated with a calcineurin inhibitor.
20146 citationsauthor #7
[Laparoscopic fenestration for a symptomatic lymphocele in renal graft after living-donor kidney transplantation].
20141 citationsauthor #11
Present Status of ABO Incompatible Kidney Transplantation in Japan-Lessons From More Than 2,400 Cases to Date-.: Abstract# 2912
20145 citationsauthor #14
Effect of donor–recipient age difference on long-term graft survival in living kidney transplantation
201413 citationsauthor #7
ABO-incompatible living-donor pediatric kidney transplantation in Japan
201426 citationsauthor #5
Efficacy of clean intermittent catheterization for urinary incontinence in patients with neurogenic lower urinary tract dysfunction secondary to myelodysplasia
20140 citationsauthor #5
Effect of the time from the presentation of symptoms to medical consultation on primary tumor size and survival in patients with testicular cancer: Shift in the last 2 decades.
201423 citationsauthor #7
Tailor-made medicine of ABO incompatible renal transplant recipients dsensitivity test at the beginning of desensitization therapy and just before operationesigned by lymphocyteimmunosuppressant
20140 citationsauthor #9
ABO-Incompatible Kidney Transplantation : The Surprising Absence of Hyperacute Rejection [Innovation in Transplant and Regenerative Medicine. The 13th Meeting of Hirosaki International Forum of Medical Science. Communication Center of Hirosaki University School of Medicine. September 9, 2011, Hirosa
20130 citationsauthor #1
Oncological outcomes in patients with stage I testicular seminoma and nonseminoma: pathological risk factors for relapse and feasibility of surveillance after orchiectomy
201332 citationsauthor #7
Decrease in lean body mass in men with prostate cancer receiving androgen deprivation therapy: mechanism and biomarkers.
201313 citationsauthor #6
Lower urinary tract symptoms in patients with Niigata Minamata disease: A case–control study 50 years after methyl mercury pollution
201310 citationsauthor #3
The RENAL Nephrometry Score and the PADUA Classification for the Prediction of Perioperative Outcomes in Patients Receiving Nephron-Sparing Surgery: Feasible Tools to Predict Intraoperative Conversion to Nephrectomy
201330 citationsauthor #7
Androgen deprivation promotes intratumoral synthesis of dihydrotestosterone from androgen metabolites in prostate cancer
201383 citationsauthor #8
446 IMPACT OF LAPAROSCOPIC NEPHRECTOMY ON HEALTH RELATED QUALITY OF LIFE: COMPARISON BETWEEN RENAL CANCER PATIENTS AND HEALTHY KIDNEY DONORS
20130 citationsauthor #5
The role of naftopidil in the management of benign prostatic hyperplasia
201321 citationsauthor #4
[The new immunosuppressive drugs for renal transplantation: inhibitors of the mammalian target of rapamycin (mTOR) and anti-thymocyte globulin (Thymoglobulin)].
20130 citationsauthor #5
Retroperitoneoscopic donor nephrectomy with a gel-sealed hand-assist access device
20138 citationsauthor #6
Randomized comparative trial of mizoribine versus mycophenolate mofetil in combination with tacrolimus for living donor renal transplantation
201320 citationsauthor #2
Efficacy and safety of concentration-controlled everolimus with reduced-dose cyclosporine in Japanese de novo renal transplant patients: 12-month results
201337 citationsauthor #1
Comparison of the Pharmacological Efficacies of Immunosuppressive Drugs Evaluated by the ATP Production and Mitochondrial Activity in Human Lymphocytes.
20135 citationsauthor #9
Peripheral Lymphocyte Response to Mycophenolic Acid In Vitro and Incidence of Cytomegalovirus Infection in Renal Transplantation.
20132 citationsauthor #9
Clinical Significance of the Pharmacological Efficacy of Tacrolimus Estimated by the Lymphocyte Immunosuppressant Sensitivity Test (LIST) Before and After Renal Transplantation.
20126 citationsauthor #8
Comparative Study of the Cellular Pharmacodynamics of Tacrolimus in Renal Transplant Recipients Treated with and without Basiliximab
201215 citationsauthor #9
Final height in a prospective trial of late steroid withdrawal after pediatric renal transplantation treated with cyclosporine and mizoribine
20126 citationsauthor #12
Pentraxin‐3 expression in acute renal allograft rejection
201230 citationsauthor #9
Deficiency in androgens and upregulation of insulin-like growth factor-1 are involved in high bone turnover in men receiving androgen deprivation therapy for prostate cancer.
20127 citationsauthor #7
Laparoscopic Surgery in Urology (Arthroscopic Surgery : Present and Future)
20120 citationsauthor #10
A case of kidney graft failure due to nonadherence
20121 citationsauthor #7
759 UNAFFECTED INTERLEUKIN-6 LEVEL DESPITE INCREASED BODY FAT DURING ANDROGEN DEPRIVATION THERAPY (ADT) COORDINATE REGULATION BETWEEN SEX STEROIDS AND INTERLEUKIN-6 IS ASSOCIATED WITH ADT-RELATED BODY COMPOSITION CHANGE
20120 citationsauthor #4
Prediction of pathological and oncological outcomes based on extended prostate biopsy results in patients with prostate cancer receiving radical prostatectomy: a single institution study
201217 citationsauthor #8
Performance of the Japanese GFR equation in potential kidney donors
201220 citationsauthor #14
Clinical Pharmacokinetics of Once-Daily Tacrolimus Formulations in De Novo Kidney Transplantation: 1854
20120 citationsauthor #3
Concentration-Controlled Everolimus with Reduced Cyclosporine Concentration in Japanese De Novo Renal Transplant Recipients: Efficacy and Safety Results at 12 Months: Japanese Multicenter Study: 1517
20121 citationsauthor #8
Abstract 960: Intratumoral dihydrotestosterone regulation by conversion of androstanediol to dihydrotestosterone in prostate cancer
20120 citationsauthor #8
484 THE TRANSCRIPTOMICS OF INTRATUMORAL ANDROGEN BIOSYNTHESIS FROM ADRENAL ANDROGEN IN PROSTATE CANCER CELLS FOLLOWING ANDROGEN DEPRIVATION: ESTABLISHMENT OF CASTRATION-RESISTANT MODEL
20120 citationsauthor #4
Analysis of Causative Factors of Non-Function Kidney in 2453 Kidney Transplants from Non-Heart-Beating Deceased Donors: 1672
20120 citationsauthor #3
[A case of true ureteral diverticulum on functional solitary kidney].
20122 citationsauthor #6
Insulin-like growth factor-1 is associated with regulation of the luteinizing hormone production in men receiving androgen deprivation therapy with gonadotropin-releasing hormone analogues for localized prostate cancer.
201211 citationsauthor #7
Altered association of interleukin‐6 with sex steroids in lipid metabolism disorder in men with prostate cancer receiving androgen deprivation therapy
201211 citationsauthor #8
Profiling of kidney vascular endothelial cell plasma membrane proteins by liquid chromatography–tandem mass spectrometry
20128 citationsauthor #13
UP-02.185 Associations Among Anabolic Endocrine Axes in Patients with Prostate Cancer Receiving Androgen Deprivation Therapy
20110 citationsauthor #5
30 LAPAROSCOPIC ADRENALECTOMY FOR PHEOCHROMOCYTOMA WITHOUT INITIAL SECTION OF THE ADRENAL VEIN: EVALUATION OF EXPERIENCE AT A SINGLE INSTITUTE
20110 citationsauthor #3
Proteomic mapping of kidney and liver endothelial ce l surface proteins
20110 citationsauthor #7
MP-11.10 Free Tube Graft Urethroplasty for Repair of Hypospadias with Chordee
20110 citationsauthor #8
286 5α-ANDROSTANE-3α 17β-DIOL WILL BE A POTENTIAL PRECURSOR OF THE MOST ACTIVE ANDROGEN 5α-DIHYDROTESTOSTERONE IN PROSTATE CANCER
20112 citationsauthor #6
Retroperitoneoscopic nephrectomy using a GelPort as the main access platform with a muscle-splitting approach: initial clinical experience
20110 citationsauthor #6
1111 ALTERED ACTIVITY IN EACH PITUITARY-GONADAL, PITUITARY-ADRENAL, AND GH/IGF-1 ENDOCRINE AXIS IS ASSOCIATED WITH BONE METABOLIC DISORDER IN PATIENTS WITH PROSTATE CANCER RECEIVING ANDROGEN DEPRIVATION THERAPY
20110 citationsauthor #7
External validation of the UCSF-CAPRA (University of California, San Francisco, Cancer of the Prostate Risk Assessment) in Japanese patients receiving radical prostatectomy.
201115 citationsauthor #11
The case of BK virus infection in which it was difficult to differentiate from acute rejection
201111 citationsauthor #7
Kattan postoperative nomogram for renal cell carcinoma: Predictive accuracy in a Japanese population
201119 citationsauthor #5
Clinical Feature of Men Who Benefit from Dose Escalation of Naftopidil for Lower Urinary Tract Symptoms: A Prospective Study
201110 citationsauthor #6
Detection of allogeneic blood group A and B enzyme activities in patients with ABO incompatible kidney transplantation.
20106 citationsauthor #6
1566 IMPACT OF ANDROGEN DEPRIVATION THERAPY ON ANDROGEN LEVELS AND ASSOCIATION BETWEEN TUMOR MALIGNANT POTENTIAL AND ANDROGEN MILIEU IN PATIENTS WITH LOCALIZED PROSTATE CANCER
20100 citationsauthor #6
Two distinct FSGS lesions caused by distinct etiology confirmed in a single patient in pre‐ and post‐transplantation
20102 citationsauthor #9
Trilostane, an inhibitor of 3β-hydroxysteroid dehydrogenase, has an agonistic activity on androgen receptor in human prostate cancer cells.
201016 citationsauthor #7
228 HISTOPATHOLOGICAL EFFECTS AFTER ANDROGEN DEPRIVATION THERAPY ARE ASSOCIATED WITH ALTERED EXPRESSION OF ANDROGEN METABOLIC ENZYMES IN LOCALIZED PROSTATE CANCER
20100 citationsauthor #8
Adrenocorticotropic hormone is involved in regulation of androgen synthesis in men receiving androgen deprivation therapy for localized prostate cancer.
20107 citationsauthor #6
Serum prostate‐specific antigen levels reflect the androgen milieu in patients with localized prostate cancer receiving androgen deprivation therapy: Tumor malignant potential and androgen milieu
201031 citationsauthor #6
Decline of the red blood cell count in patients receiving androgen deprivation therapy for localized prostate cancer: impact of ADT on insulin-like growth factor-1 and erythropoiesis.
201025 citationsauthor #6
Mechanism of acute antibody-mediated rejection in ABO-incompatible kidney transplantation: which anti-A/anti-B antibodies are responsible, natural or de novo?
201018 citationsauthor #1
NEW REGISTRY AND TRACKING SYSTEM FOR RENAL TRANSPLANTATION IN JAPAN: 1298
20100 citationsauthor #4
Successful treatment of nonocclusive mesenteric ischemia that developed during the peritransplant period following ABO-incompatible kidney transplantation
20102 citationsauthor #11
947 FUNCTIONAL INACTIVATION OF INSULIN-LIKE GROWTH FACTOR-1 IN THE BONE MAY BE RELEVANT TO OSTEOPOROSIS DURING ANDROGEN DEPRIVATION THERAPY
20100 citationsauthor #4
Customized Treatment Planning to Improve the Dose Distribution in Fractionated High Dose Rate Brachytherapy Boost for Prostate Cancer
20100 citationsauthor #9
Parathyroid hormone‐related peptide‐producing non‐familial pheochromocytoma in a child
201022 citationsauthor #5
Kinetics of serum total and free prostate-specific antigen (PSA) after extended multisite prostate biopsy: Comparison among biopsy, transurethral resection of the prostate (TURP), and biopsy plus TURP.
20102 citationsauthor #7
The pharmacological efficacy of mycophenolic acid before and after renal transplantation as estimated by the lymphocyte immunosuppressant sensitivity test (LIST)
20106 citationsauthor #9
RELEVANCE OF CONTINUOUS DETECTION OF ALLOGENEIC BLOOD GROUP A AND B ENZYMES TO SUCCESSFUL ABO INCOMPATIBLE KIDNEY TRANSPLANTATION: 406
20100 citationsauthor #7
Efficacy of Clean Intermittent Catheterization for Urinary Incontinence in Children with Neurogenic Bladder Dysfunction Secondary to Myelodysplasia
20104 citationsauthor #6
MULTIVARIATE ANALYSIS OF CAUSATIVE FACTORS OF NON-FUNCTION KIDNEY IN 1856 KIDNEY TRANSPLANTS FROM NON-HEART-BEATING DECEASED DONORS.: 3056
20101 citationsauthor #3
233 TRILOSTANE, AN INHIBITOR OF 3BETA-HYDROXYSTEROID DEHYDROGENASE, HAS AN AGONISTIC ACTIVITY FOR ANDROGEN RECEPTORS IN THE PROSTATE CANCER CELLS
20101 citationsauthor #6
[Organizing medical institutions for organ donation].
20100 citationsauthor #4
THE EXPRESSION FEATURES OF ANDROGEN-METABOLIC GENES INVOLVING INTRACRINE PRODUCTION OF ANDROGENS IN THE PROSTATE CANCER CELLS
20090 citationsauthor #7

TIMELINE

1981 0 citations

1986 4 citations

1987 0 citations

1988 0 citations

1989 5 citations

1990 0 citations

1991 13 citations

1992 25 citations

1993 3 citations

1994 0 citations

1995 64 citations

1996 177 citations

1997 204 citations

1998 297 citations

1999 373 citations

2000 245 citations

2001 259 citations

2002 139 citations

2003 248 citations

2004 758 citations

2005 364 citations

2006 446 citations

2007 283 citations

2008 134 citations

2009 95 citations

2010 143 citations

2011 57 citations

2012 135 citations

2013 261 citations

2014 74 citations

2015 21 citations

2016 110 citations

2017 22 citations

2018 27 citations

2019 33 citations

2020 5 citations

2022 7 citations

2023 13 citations

Kota Takahashi

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT